OVERVIEW

The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare. The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine. The SBMT globally promotes interdisciplinary research to improve the diagnosis, treatment, and rehabilitation of patients with central nervous system diseases regardless of race, creed, color, national origin, gender, or age. The SBMT catalyzes interactions between clinical, biological, physical and engineering sciences. The Society builds transdisciplinary and translational consortia which break down traditional barriers that impede application of new technology to medical problems. Translational research applies cutting edge basic science and advanced technologies to clinical neurosciences. The Society examines emerging disciplines such as nanotechnology, image-guided therapy, stem cell therapy, multi-modality imaging, biophotonics, and biomaterial and tissue engineering for their application to the diagnosis, treatment, and rehabilitation from neurological diseases. The Society seeks to apply these technologies to clinical problems such as brain tumors, stroke, epilepsy, neurodegenerative diseases (Parkinson, Alzheimer, multiple sclerosis and ALS), traumatic brain and spinal cord injuries, autism, post traumatic stress disorder and other psychiatric illnesses. The Society achieves its goals through meetings, fellowships, publications, international collaborations, consortiums, and policy forums. The SBMT is a nonprofit society which has obtained support from many government agencies (USA, EU and Asia), foundations, and multi-national corporations.

KEY DATES

Event Start Date
14 Mar, 2027
Event Start Date
Event End Date
17 Mar, 2027
Event End Date
Credits

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Loma Linda University School of Medicine and Society of Brain Mapping Therapeutics. The Loma Linda University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The Loma Linda University School of Medicine designates this Live Activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1: The Loma Linda University School of Medicine designates this Live Activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 12 AMA PRA Category 1
  • TARGET AUDIENCE

    PhysicianAdvanced Practice ProvidersPhysician AssistantNurse PractitionerResearch scientistsPrimary Clinicians

    SPECIALITIES

    NeurosurgeryNeuroscience

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationLos Angeles Convention Center
    1201 South Figueroa Street

    RELATED CONFERENCES & LIVE WEBINARS